InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (56 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
56
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Azamian Bobak R., Chief Executive Officer. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. In total, 60 reports have been logged. Split: 0 buy · 56 sells. Total volume traded: €6.2m. Activity tracked since 5 August 2021. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Azamian Bobak R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations60 total
4,582 sharesCommon StockSEC:0001827672-26-000009:0
5,418 sharesCommon StockSEC:0001827672-26-000009:1
10,972 shares@ US$69.4211.2% of flowCommon StockSEC:0001827672-26-000007:0
66,274 sharesCommon StockSEC:0001827672-26-000005:0
557 shares@ US$83.540.7% of flowCommon StockSEC:0001827672-25-000007:1
5,443 shares@ US$82.417.1% of flowCommon StockSEC:0001827672-25-000007:0
51,885 shares0Common StockSEC:0001827672-25-000005:0
6,000 shares@ US$55.374.6% of flowCommon StockSEC:0001827672-25-000003:0
6,000 shares@ US$50.004.4% of flowCommon StockSEC:0001819790-25-000110:0
6,000 shares@ US$50.005.1% of flowCommon StockSEC:0001819790-25-000061:0
7,131 shares@ US$46.295.6% of flowCommon StockSEC:0001819790-25-000055:0
51,395 sharesCommon StockSEC:0001819790-25-000046:0
28,274 sharesCommon StockSEC:0001819790-24-000045:0
8,000 shares@ US$20.222.7% of flowCommon StockSEC:0001827672-23-000050:0
9,443 shares@ US$19.963.2% of flowCommon StockSEC:0001827672-23-000048:0
2,896 shares@ US$18.010.9% of flowCommon StockSEC:0001827672-23-000045:0
8,000 shares@ US$13.241.9% of flowCommon StockSEC:0001827672-23-000043:0
8,000 shares@ US$17.213.3% of flowCommon StockSEC:0001827672-23-000041:0
8,000 shares@ US$17.232.4% of flowCommon StockSEC:0001827672-23-000039:0
4,174 shares@ US$19.281.3% of flowCommon StockSEC:0001827672-23-000037:0
9,000 shares@ US$17.352.6% of flowCommon StockSEC:0001827672-23-000035:0
8,000 shares@ US$18.632.5% of flowCommon StockSEC:0001819790-23-000048:0
9,000 shares@ US$18.582.9% of flowCommon StockSEC:0001827672-23-000033:0
3,100 shares@ US$20.011.1% of flowCommon StockSEC:0001209191-23-036433:0
8,000 shares@ US$15.902.2% of flowCommon StockSEC:0001827672-23-000031:0
25 of 60 declarations
About Azamian Bobak R.
Azamian Bobak R. is Directeur Général and is linked to Tarsus Pharmaceuticals, Inc., where he holds the role of President/CEO and Board Chair. He has 60 filings in total, and across the 60 sampled filings, they cover sales between 2021-08-06 and 2026-06-22, for a total of EUR 6196570 in sales and EUR 0 in purchases.
